
    
      1. Enrollment

             -  ear-nose-throat (ENT) examination + oesophagoscopy

             -  immunological assessment

                  -  assessment of selected humoral (antibodies) and

                  -  cellular immune response parameters(INF gamma and granzyme B testing)

                  -  in vitro and in vivo stimulation of PMBCs with the HPV-4 vaccine

        2. Immunization with 4-valent HPV vaccine at 0,2,6 months

        3. Follow up

             -  1 month after 3rd vaccine dose - immunological assessment (same tests as in the
                enrollment phase)

             -  6, 12 and 18 months after the 3rd vaccine dose - ENT + oesophagoscopy
    
  